The vaccines, which are made from melanoma cells, are able to trigger an immune response in about half the patients.

The vaccine uses a synthetic version of a ganglioside protein commonly found on melanoma cells.

"Clearly the melanoma cells must have started growing slowly and migrated to the lymph node."

This procedure is now used extensively, for example by fusing B-cells with melanoma cells.

These complexes can be found on the surface of melanoma cells.

The offspring, pure strains of their species, produce melanoma cells strikingly similar to those produced by the human body.

The type of melanoma cells (how they look under a microscope).

High doses inhibit growth and proliferation of melanoma cells.

It allows for the inhibition of growth in human melanoma cells.

The vaccine is made from membranes of melanoma cells which have been infected with vaccinia virus.